Home › NDC Lookup › RxCUI directory › RxCUI 2184108

Dexchlorpheniramine maleate 2 MG / phenylephrine hydrochloride 10 MG Oral Tablet — RxCUI 2184108

Name: Dexchlorpheniramine maleate 2 MG / phenylephrine hydrochloride 10 MG Oral Tablet (RxCUI 2184108)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2184108 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2184108

Official nameDexchlorpheniramine maleate 2 MG / phenylephrine hydrochloride 10 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asdexchlorpheniramine maleate 2 MG / phenylephrine HCl 10 MG Oral Tablet

FDA products mapped1

Package NDCs mapped1

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Phenylephrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It depends on the product. The injection raises low blood pressure during anesthesia and, for some products, septic shock. Eye drops dilate the pupil, nasal products relieve conges...
Be careful. Over-the-counter phenylephrine should not be used with a prescription MAOI or within 2 weeks of stopping one. If you aren't sure whether your medicine is an MAOI, ask m...
With the injection, the most common are nausea, vomiting and headache. Call for help right away if you have chest pain, a very slow heartbeat, or pain or skin changes around the IV...
Stop and talk to a doctor if you get nervousness, dizziness or sleeplessness. Also stop if symptoms last more than 7 days or come with a fever. Don't use more than the label recomm...

📖 Read our full Phenylephrine guide →

🕸️ Concept Web — How Dexchlorpheniramine maleate 2 MG / phenylephrine... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Dexchlorpheniramine maleate 2 MG / phenylephrine hydrochloride 10 MG Oral Tablet RxCUI 2184108 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 5

The active substance itself — no strength, form, or brand attached yet.
- Dexchlorpheniramine 22697 IN
- Phenylephrine 8163 IN
- Dexchlorpheniramine / phenylephrine 728498 MIN
- Dexchlorpheniramine maleate 54828 PIN
- Phenylephrine hydrochloride 8164 PIN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Dexchlorpheniramine / phenylephrine Oral Tablet 723519 SCDF
- Dexchlorpheniramine maleate / phenylephrine hydrochloride Oral Tablet 2645578 SCDFP
- Dexchlorpheniramine / phenylephrine Oral Product 1157790 SCDG
- Dexchlorpheniramine / phenylephrine Pill 1157791 SCDG
- Dexchlorpheniramine maleate / phenylephrine hydrochloride Oral Product 2663541 SCDGP
- Dexchlorpheniramine maleate / phenylephrine hydrochloride Pill 2662745 SCDGP
- Oral Tablet 317541 DF
- Oral Product 1151131 DFG
- +1 more in this family
Clinical & branded drugs 2

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Dexchlorpheniramine maleate 2 MG 1293238 SCDC
- Phenylephrine hydrochloride 10 MG 996705 SCDC

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Dexchlorpheniramine maleate 2 MG SCDC · 1293238
Phenylephrine hydrochloride 10 MG SCDC · 996705
Dexchlorpheniramine / phenylephrine Oral Tablet SCDF · 723519
Dexchlorpheniramine maleate / phenylephrine hydrochloride Oral Tablet SCDFP · 2645578
Dexchlorpheniramine / phenylephrine Oral Product SCDG · 1157790
Dexchlorpheniramine / phenylephrine Pill SCDG · 1157791
Dexchlorpheniramine maleate / phenylephrine hydrochloride Oral Product SCDGP · 2663541
Dexchlorpheniramine maleate / phenylephrine hydrochloride Pill SCDGP · 2662745

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 2184108 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00485-0080-01	100 TABLET, COATED in 1 BOTTLE, PLASTIC (0485-0080-01)	RYMED	EDWARDS PHARMACEUTICALS, INC.	2011-11-15

Observed labelers: EDWARDS PHARMACEUTICALS, INC. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ea · median

$0.2240

Range $0.2240–$0.2240 · middle 50% $0.2240–$0.2240 · 1 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.